Houston-based Complete Intelligence was just recognized by Capital Factory as the "Newcomer of the Year." Photo via completeintel.com

The business applications of artificial intelligence are boundless. Tony Nash realized AI's potential in an underserved niche.

His startup, Complete Intelligence, uses AI to focus on decision support, which looks at the data and behavior of costs and prices within a global ecosystem in a global environment to help top-tier companies make better business decisions.

"The problem that were solving is companies don't predict their costs and revenues very well," says Nash, the CEO and founder of Complete Intelligence. "There are really high error rates in company costs and revenue forecasts and so what we've done is built a globally integrated artificial intelligence platform that can help people predict their costs and their revenues with a very low error rate."

Founded in 2015, Complete Intelligence is an AI platform that forecasts assets and allows evaluation of currencies, commodities, equity indices and economics. The Woodlands-based company also does advanced procurement and revenue for corporate clients.

"We've spent a couple years building this," says Nash. "We have a platform that is helping clients with planning, finance, procurement and sales and a host of other things. We are forecasting equity markets; we are forecasting commodity prices, currencies, economics and trades. We built a model of the global economy and transactions across the global economy, so it's a very large, very detailed artificial intelligence platform."

That platform, CI Futures, has streamlined comprehensive price forecasting and data analysis, allowing for sound, data-based decisions.

"Our products are pretty simple," says Nash. "We have our basic off the shelf forecast which is called CI Futures, which is currencies, commodities, equities and economics and trade. Its basic raw data forecasts. We distribute that raw data on our website and other data distribution websites. We also have a product called Cost Flow, which is our procurement forecasting engine, where we build a material level forecasting for clients.


completeintel.com

"Then we have a product that we'll launch next year called Revenue Flow, which is a sales forecasting tool that will use balance of both client data and publicly available data to forecast client sales by product, by geography and so on and so forth. So we really only do three things: revenues, costs and raw data forecasts."

Forecasting across industries

Complete Intelligence's Cost Flow and Revenue Flow products are specific to direct clients. They are working with clients in the food and beverage sector, the energy sector, the chemical sector, and the technology sector.

"Anybody that manufactures a tangible good, should use our product," says Nash. "Because we can take their historical data we can configure their bills of material and they can see the exact cost and exact revenue of those products by month over time."

CI is not a consulting firm, so they offer their clients an annual license, which allows them to receive updated forecasts every month to understand how markets will iterate over time.

"We're integrating with the client's enterprise data," says Nash. "Whether it's their ERP system or their procurement system or their CRM, we're integrating with client's enterprise data, and we're creating forecast outlooks that are perfectly contextually relevant for client buying decisions."

Called out by Capital Factory

As a business solution, CI has garnered widespread industry confidence and accolades, such as Capital Factory's coveted "Newcomer of the Year" award, which recognizes innovative companies from a pool of 110 startups in Texas.

"Honestly, I couldn't believe it because with a startup like ours, there's so much hard work that goes into it, there's so much time, there's so much persistence," says Nash.

"And the types of startups that Capital Factory attracts are very competitive startups, so for us to receive this award, it's given us a huge amount of credibility in the market and it's really encouraged the team inside the company to understand that what we're doing is being recognized, it's meaningful and we're really going places."

From consulting to billions of monthly calculations

Nash is no stranger to going places. Before setting up shop in his native Texas, he lived in Singapore for 15 years where he started his career in sourcing and procurement for American retail firms.

"I became very sensitive to costs, cost inflections and I got very involved in global sourcing and international trade and then I did a couple of corporate turnarounds and start ups and so with that you see costs as an issue with those types of firms," Nash says.

He then worked with the Economist running their global research business. There, he grew familiar with how clients and customers use data. At IHS Markit, a global information provider.

"When I was working with those firms, those firms helped companies with planning," says Nash. "The problem is that those firms have very large errors in their forecasts. It is not just the internal forecasts that have a 30 percent or higher error rate in their forecasts, even the industry forecasters typically have around a 20 percent error rates in their forecasts.

"Even the people who should actually know where prices are going are not very good forecasters. With Complete Intelligence, we wanted to use data and use artificial intelligence to machine learning to create a better way to identify where costs and revenues will go for companies."

Every month, CI runs billions of calculations. They test their error rates and record them for clients that request them. With 700 assets that they show publicly, CI their average error rate is 3.7 percent, which is dramatically lower than both corporate procurement professionals and industry experts.

"With us doing billions of calculations, it allows us to run simulations and scenarios that your average analyst just can't do and most companies haven't even thought of. We're able to run a comprehensive view of activities in the world to understand how things directly and indirectly affect a cost. In Houston, for example, that could be crude oil or natural gas or something like that."

Proving its value

Last year, the company tested its platform with a natural gas trader. After reviewing the data, CI revealed to the client that natural gas would fall by 40 percent over the next year.

"They looked at our forecast and said they couldn't work with us because it didn't make sense," says Nash. "A 40 percent fall didn't make sense, so they didn't subscribe to us. That was 2018. What has happened over the past 12 months? Natural gas prices had fallen by 49 percent. You would look at our forecasts and say, 'Wow, that's a dramatic drop over 12 months.' But reality was even more dramatic than that and there weren't analysts out there saying what our model was telling us."

That natural gas trading company never admitted its faux pas, but if they had listened to CI, they could have positioned themselves to negotiate their vendors down for their cost base, which helps the margin of their business.

"Nobody ever admits mistakes," says Nash. "But when you think about the numerous materials that require natural gas, especially things that are manufactured in Houston, it affects a lot of costs."

Houston roots — by way of Asia

The missed opportunity with the natural gas trader notwithstanding, Nash is happy that he brought Complete Intelligence to Houston.

"I went to Texas A&M and grew up in Texas, so I moved back to Texas knowing how good Americans are with planning, with math and with data. I like Houston because people make stuff in Houston," Nash says. "We just found Houston to be perfect after spending 15 years in Asia given the global centrality of Houston. The industry's here and there's a lot of diversity in Houston."

Nash's expectation was that he would be able to work with Western multinationals to improve their analytics and their artificial intelligence processes because he has learned that there is a lot of pressure in American financial markets and analysts communities to really know what is happening within companies.

"We want companies to be able to really tightly plan their costs so they can better improve their profitability," says Nash. "That's what I wanted to do when we moved to the U.S. and we're finding that there's a lot of interest from companies."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”